Clinical Trial Update: Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating antiandrogen therapy with or without Axitinib before surgery in untreated prostate cancer with known or suspected lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Antiandrogen therapy
• Axitinib (Axitinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Malignant Neoplasm in Lymph Node, Prostate Ductal Adenocarcinoma | Phase 2 | Status: COMPLETED